APG Asset Management US’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
APG Asset Management US's GILD Position: Q4 2025 in Review
APG Asset Management US sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 25,728 shares — an estimated $2.86M sold.
APG Asset Management US first reported a position in GILD in Q4 2023 and held it in 8 quarters. The position peaked at $26.3M in Q1 2024. 2,227 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- APG Asset Management US reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- APG Asset Management US sold 25,728 Gilead Sciences shares in Q4 2025, an estimated $2.86M.
- APG Asset Management US first reported a position in Gilead Sciences in Q4 2023 and held it in 8 quarters.
- APG Asset Management US's Gilead Sciences position peaked at $26.3M in Q1 2024.
- 2,227 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.